Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Northwest Pipe Shares Present a Contradictory Picture

Dieter Jaworski by Dieter Jaworski
December 13, 2025
in Analysis, Industrial, Insider Trading
0
Northwest Pipe Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

The stock of Northwest Pipe Company is currently trading in a consolidation pattern near its 52-week highs, presenting investors with a complex set of signals. While institutional money is flowing in, corporate insiders have been consistent sellers over the past half-year, creating a notable divergence for market participants to consider.

Financial Performance and Valuation

The company’s recent third-quarter report provided a significant catalyst for the equity. Northwest Pipe posted earnings per share of $1.38, soundly beating the consensus estimate of $1.02. Revenue came in at $151.1 million, also surpassing expectations of $132 million. In response, DA Davidson raised its price target from $60 to $70 per share, reaffirming a “Buy” rating. Trading with a price-to-earnings ratio of approximately 15.4, the valuation suggests room for relative appreciation compared to the broader industrial sector. Further fundamental support is derived from the performance of its Precast Infrastructure and Engineered Systems segment and recent operational accolades.

Conflicting Activity: Institutions vs. Insiders

A clear dichotomy defines current market activity. On one hand, institutional investors have demonstrated confidence. Panagora Asset Management notably established a new position, acquiring approximately 28,083 shares worth around $1.15 million. Such external demand is typically viewed as a positive indicator.

Should investors sell immediately? Or is it worth buying Northwest Pipe?

Conversely, insider selling has been persistent. Over the last six months, regulatory filings document eight verified sales with no corresponding purchases by company officers. Notably, CEO Scott J. Montross sold 8,210 shares (worth roughly $470,000) on November 11, while Executive Vice President Miles Brittain divested 4,000 shares on November 24. The sale by Montross was executed under a pre-arranged 10b5-1 trading plan. Although the absence of insider buying can temper sentiment, it does not alone constitute a definitive bearish signal.

Price Action and Technical Perspective

Shares closed Friday’s session at $63.53, marking a daily gain of 1.1%. This advance continues a period of stability near the stock’s annual peak. The immediate technical hurdle is seen at the $65 resistance level. A sustained breakout above this point would confirm the prevailing positive momentum. For now, the price action reflects a sideways consolidation.

Forward Outlook

The market’s focus will likely remain on the balance between continued institutional accumulation and the potential for further insider disposals. The next significant catalyst for reevaluation is anticipated to be the fourth-quarter earnings release, expected in February 2026. Until then, the share price may continue to reflect the tension between these opposing forces of demand.

Ad

Northwest Pipe Stock: Buy or Sell?! New Northwest Pipe Analysis from February 8 delivers the answer:

The latest Northwest Pipe figures speak for themselves: Urgent action needed for Northwest Pipe investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Northwest Pipe: Buy or sell? Read more here...

Tags: Northwest Pipe
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Quanterix Stock
Analysis

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Next Post
Glaukos Stock

Divergent Signals Emerge for Glaukos Stock

Uranium Energy Stock

Uranium Energy's Strategic Pivot: From Exploration to Active Production

Rocket Lab USA Stock

Rocket Lab's Stock Surge: A Closer Look at the Underlying Risks

Recommended

Biotechnology Stock Exchange

Analysts Bullish on Dynatrace with Price Targets on the Rise

2 years ago
The Trade Desk Stock

The Trade Desk Faces Mounting Pressure as Amazon Strikes Netflix Deal

5 months ago

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Trending

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

by Jackson Burston
February 8, 2026
0

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its...

Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com